Foster Dykema Cabot & Partners’s CVS Health CVS Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.53K	Hold	63	–	–	﹤0.01%	277
2025 Q4	$5K	Sell	63 -31	-33%	-$2.44K	﹤0.01%	284
2025 Q3	$7.09K	Buy	94 +67	+248%	+$4.59K	﹤0.01%	358
2025 Q2	$1.86K	Hold	27	–	–	﹤0.01%	327
2025 Q1	$1.83K	Hold	27	–	–	﹤0.01%	324
2024 Q4	$1.21K	Sell	27 -333	-93%	-$18.7K	﹤0.01%	361
2024 Q3	$22.6K	Sell	360 -300	-45%	-$17.5K	﹤0.01%	300
2024 Q2	$39K	Buy	660 +166	+34%	+$10.4K	﹤0.01%	188
2024 Q1	$39.4K	Sell	494 -5	-1%	-$382	﹤0.01%	191
2023 Q4	$39.4K	Buy	+499	New	+$35.5K	﹤0.01%	165

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Foster Dykema Cabot & Partners's CVS Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its CVS Health (CVS) position steady in Q1 2026 at 63 shares worth $4.53K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Foster Dykema Cabot & Partners first reported a position in CVS in Q4 2023 and has held it in 10 quarters since. The position peaked at $39.4K in Q1 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Foster Dykema Cabot & Partners held 63 shares of CVS Health worth $4.53K as of Q1 2026.
Foster Dykema Cabot & Partners left its CVS Health share count unchanged in Q1 2026.
CVS Health made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #277 holding.
Foster Dykema Cabot & Partners first reported a position in CVS Health in Q4 2023 and has held it in 10 quarters since.
Foster Dykema Cabot & Partners's CVS Health position peaked at $39.4K in Q1 2024.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.